vs
Side-by-side financial comparison of LiveWire Group, Inc. (LVWR) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
LiveWire Group, Inc. is the larger business by last-quarter revenue ($11.4M vs $9.1M, roughly 1.2× Protalix BioTherapeutics, Inc.). Protalix BioTherapeutics, Inc. runs the higher net margin — -60.3% vs -155.2%, a 94.9% gap on every dollar of revenue. On growth, LiveWire Group, Inc. posted the faster year-over-year revenue change (5.5% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-8.9M). Over the past eight quarters, LiveWire Group, Inc.'s revenue compounded faster (51.0% CAGR vs -6.7%).
LiveWire is an American electric motorcycle manufacturer. It was initially launched as a dedicated electric vehicle (EV) division for Harley Davidson in July 2021. The company was spun-off from its parent and went public on September 27, 2022, via merger with a special-purpose acquisition company (SPAC). It was the first publicly traded electric motorcycle company in the United States.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
LVWR vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.4M | $9.1M |
| Net Profit | $-17.6M | $-5.5M |
| Gross Margin | 0.8% | 49.4% |
| Operating Margin | -156.2% | -51.1% |
| Net Margin | -155.2% | -60.3% |
| Revenue YoY | 5.5% | -49.9% |
| Net Profit YoY | 22.6% | -184.8% |
| EPS (diluted) | $-0.09 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.4M | $9.1M | ||
| Q3 25 | $5.7M | $17.9M | ||
| Q2 25 | $5.9M | $15.7M | ||
| Q1 25 | $2.7M | $10.1M | ||
| Q4 24 | $10.8M | $18.2M | ||
| Q3 24 | $4.4M | $18.0M | ||
| Q2 24 | $6.4M | $13.5M | ||
| Q1 24 | $5.0M | — |
| Q4 25 | $-17.6M | $-5.5M | ||
| Q3 25 | $-19.4M | $2.4M | ||
| Q2 25 | $-18.8M | $164.0K | ||
| Q1 25 | $-19.3M | $-3.6M | ||
| Q4 24 | $-22.8M | $6.5M | ||
| Q3 24 | $-22.7M | $3.2M | ||
| Q2 24 | $-24.8M | $-2.2M | ||
| Q1 24 | $-23.6M | — |
| Q4 25 | 0.8% | 49.4% | ||
| Q3 25 | -50.9% | 53.4% | ||
| Q2 25 | 9.3% | 62.5% | ||
| Q1 25 | -79.0% | 19.1% | ||
| Q4 24 | -49.8% | 78.7% | ||
| Q3 24 | -34.2% | 53.4% | ||
| Q2 24 | -27.6% | 29.8% | ||
| Q1 24 | -82.9% | — |
| Q4 25 | -156.2% | -51.1% | ||
| Q3 25 | -330.0% | 11.9% | ||
| Q2 25 | -311.0% | 7.5% | ||
| Q1 25 | -753.4% | -41.0% | ||
| Q4 24 | -234.6% | 39.6% | ||
| Q3 24 | -596.7% | 22.2% | ||
| Q2 24 | -436.7% | -18.0% | ||
| Q1 24 | -611.1% | — |
| Q4 25 | -155.2% | -60.3% | ||
| Q3 25 | -340.2% | 13.2% | ||
| Q2 25 | -320.6% | 1.0% | ||
| Q1 25 | -702.6% | -35.8% | ||
| Q4 24 | -211.7% | 35.6% | ||
| Q3 24 | -510.6% | 18.0% | ||
| Q2 24 | -384.6% | -16.4% | ||
| Q1 24 | -475.0% | — |
| Q4 25 | $-0.09 | $-0.06 | ||
| Q3 25 | $-0.10 | $0.03 | ||
| Q2 25 | $-0.09 | $0.00 | ||
| Q1 25 | $-0.09 | $-0.05 | ||
| Q4 24 | $-0.11 | $0.10 | ||
| Q3 24 | $-0.11 | $0.03 | ||
| Q2 24 | $-0.12 | $-0.03 | ||
| Q1 24 | $-0.12 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $82.8M | $14.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $46.0M | $48.2M |
| Total Assets | $146.4M | $82.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.8M | $14.7M | ||
| Q3 25 | $16.3M | $13.6M | ||
| Q2 25 | $29.3M | $17.9M | ||
| Q1 25 | $46.2M | $19.5M | ||
| Q4 24 | $64.4M | $19.8M | ||
| Q3 24 | $88.4M | $27.4M | ||
| Q2 24 | $113.0M | $23.4M | ||
| Q1 24 | $141.0M | — |
| Q4 25 | $46.0M | $48.2M | ||
| Q3 25 | $61.8M | $52.9M | ||
| Q2 25 | $79.7M | $49.9M | ||
| Q1 25 | $97.2M | $45.2M | ||
| Q4 24 | $115.1M | $43.2M | ||
| Q3 24 | $137.7M | $32.4M | ||
| Q2 24 | $159.0M | $28.6M | ||
| Q1 24 | $183.8M | — |
| Q4 25 | $146.4M | $82.3M | ||
| Q3 25 | $89.2M | $82.3M | ||
| Q2 25 | $109.8M | $78.5M | ||
| Q1 25 | $128.3M | $73.9M | ||
| Q4 24 | $148.0M | $73.4M | ||
| Q3 24 | $178.3M | $61.6M | ||
| Q2 24 | $204.9M | $91.5M | ||
| Q1 24 | $237.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.9M | $2.0M |
| Free Cash FlowOCF − Capex | $-8.9M | $1.6M |
| FCF MarginFCF / Revenue | -78.7% | 17.8% |
| Capex IntensityCapex / Revenue | 9.1% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-57.4M | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.9M | $2.0M | ||
| Q3 25 | $-13.3M | $-3.7M | ||
| Q2 25 | $-14.9M | $-5.2M | ||
| Q1 25 | $-17.5M | $-5.1M | ||
| Q4 24 | $-21.9M | $4.0M | ||
| Q3 24 | $-23.1M | $4.1M | ||
| Q2 24 | $-26.0M | $-3.6M | ||
| Q1 24 | $-22.9M | — |
| Q4 25 | $-8.9M | $1.6M | ||
| Q3 25 | $-14.0M | $-4.2M | ||
| Q2 25 | $-16.3M | $-5.7M | ||
| Q1 25 | $-18.1M | $-5.4M | ||
| Q4 24 | $-23.3M | $3.6M | ||
| Q3 24 | $-24.7M | $4.0M | ||
| Q2 24 | $-27.8M | $-3.8M | ||
| Q1 24 | $-26.2M | — |
| Q4 25 | -78.7% | 17.8% | ||
| Q3 25 | -245.9% | -23.7% | ||
| Q2 25 | -277.7% | -36.2% | ||
| Q1 25 | -660.0% | -53.0% | ||
| Q4 24 | -216.3% | 19.6% | ||
| Q3 24 | -555.3% | 22.4% | ||
| Q2 24 | -431.1% | -28.1% | ||
| Q1 24 | -525.6% | — |
| Q4 25 | 9.1% | 4.4% | ||
| Q3 25 | 12.9% | 2.8% | ||
| Q2 25 | 24.3% | 2.8% | ||
| Q1 25 | 22.3% | 3.0% | ||
| Q4 24 | 13.1% | 2.3% | ||
| Q3 24 | 35.6% | 0.5% | ||
| Q2 24 | 28.5% | 1.3% | ||
| Q1 24 | 65.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LVWR
| STACYC Segment | $7.5M | 66% |
| Other | $3.8M | 34% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
